Canada signs deals with Pfizer, Moderna to get doses of COVID-19 vaccines
OTTAWA -- Canada is signing deals with pharmaceutical giant Pfizer and U.S.-based biotech firm Moderna to procure millions of doses of their experimental COVID-19 vaccines.
Procurement Minister Anita Anand is announcing the deals this morning in Toronto, which will see Canada get access to the vaccines if they prove to be both safe and effective.
Both companies began Phase 3 clinical trials of their vaccine candidates in the last week, large-scale tests to determine how well the vaccines work.
Earlier in July both Pfizer and Moderna reported positive results from smaller trials.
The Phase 3 trials will both test the vaccines on 30,000 people, and results are expected in the fall.
Canada's chief public health officer Dr. Theresa Tam warned Tuesday about expecting a vaccine to provide a quick end to the pandemic, saying they provide hope but likely no silver bullet for the novel coronavirus.
The Canadian Press
- Canada signs deals with two suppliers for potential COVID-19 vaccines
- First doses of Pfizer COVID-19 vaccine, not yet approved, to land in Canada next week
- Canadian-made COVID-19 vaccine approved for clinical trials by Health Canada
- Canada probing whether delaying second COVID-19 vaccine doses could help more people
- Canada signs deal with Novovax to get 76 million doses of COVID-19 vaccine
- Mississauga woman speechless after massive lottery win
- Mississauga church youth group leader arrested for sexual assault
- VIDEO: Mississauga Youtuber Kyle Forgeard surprises his parents by letting them retire early
- Tech startups can apply for funding and get in front of industry partners with this opportunity
- Canada Post reports more cases of COVID found at Mississauga's Gateway facility